Valuation (53%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 16.07 | 47.97 |
PEG Ratio (TTM) | 0.72 | 0.45 |
P/S Ratio (TTM) | 8.74 | 18.48 |
P/B Ratio (TTM) | 1.01 | 15.98 |
P/FCF Ratio (TTM) | 3.55 | 41.22 |
Price to 5YR AVG Earnings Ratio | N/A | 75.93 |
Price to 5YR AVG FCF Ratio | N/A | 101.74 |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.44% | -2.79% |
ROE (TTM) | 7.12% | 9.24% |
Net Profit Margin (TTM) | 368.27% | 4.10% |
ROIC 5YR AVG | N/A | 5.46% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 41.10% | 217.76% | N/A |
Revenue | -4.29% | 356.44% | N/A |
Net Income | 45.15% | 266.24% | N/A |
Cash Flow | N/A | 235.39% | N/A |
Health (51%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.85 | 1.89 |
Quick Ratio (TTM) | 2.85 | 1.88 |
D/E Ratio (TTM) | 0.13 | 0.51 |
Interest Coverage (TTM) | N/A | 12.90 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 1.12 | 10.79 |
LTL to 5YR AVG FCF | N/A | 3.97 |
Shares Outstanding Growth 5YR AVG | N/A | 51.04% |